NCT01319565 2025-12-19Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...National Institutes of Health Clinical Center (CC)Phase 2 Completed102 enrolled 12 charts